Anna Vildhede
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism 8
- Drug-Induced Hepatotoxicity and Protection 4
- Oncology top 5%
- Drug Transport and Resistance Mechanisms 17
- Hepatology top 10%
- Liver physiology and pathology 2
-
- Pharmacological Effects and Toxicity Studies 4
- Biochemistry top 10%
-
- Liver Disease Diagnosis and Treatment 8
-
- HIV/AIDS drug development and treatment 4
-
- Metabolism and Genetic Disorders 3
- Co-authors
- Per ArturssonJacek R. WiśniewskiMaria KarlgrenAgneta NorénEmi KimotoYurong LaiU HaglundUlf Norinder
- Cited by
- PharmacologyOncologyHepatology
- Journals
- Drug Metabolism and Disposition (5 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)Clinical Pharmacology & Therapeutics (2 papers)
- Partner nations
- United StatesSwedenGermany
In The Last Decade
Anna Vildhede
21 papers receiving 971 citations
Peers
Comparison fields: 5 of 91
- Pharmacology 349
- Oncology 583
- Hepatology 108
- Pediatrics, Perinatology and Child Health 251
- Biochemistry 55
Countries citing papers authored by Anna Vildhede
This map shows the geographic impact of Anna Vildhede's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Vildhede with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Vildhede more than expected).
Fields of papers citing papers by Anna Vildhede
This network shows the impact of papers produced by Anna Vildhede. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Vildhede. The network helps show where Anna Vildhede may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Anna Vildhede, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2023 | 9 | |
| 3 | 2022 | 12 | |
| 4 | 2021 | 3 | |
| 5 | 2021 | 18 | |
| 6 | 2020 | 54 | |
| 7 | 2019 | 56 | |
| 8 | 2018 | 26 | |
| 9 | 2018 | 32 | |
| 10 | 2018 | 7 | |
| 11 | 2018 | 21 | |
| 12 | 2017 | 39 | |
| 13 | 2017 | 10 | |
| 14 | 2017 | 20 | |
| 15 | 2016 | 142 | |
| 16 | 2016 | 45 | |
| 17 | 2015 | 93 | |
| 18 | Comparative proteomics of human liver tissue and hepatocytes reveal systematic differences in proteins determining hepatic drug exposure | 2015 | 0 |
| 19 | 2014 | 97 | |
| 20 | Specific and general inhibitors of the three hepatic organic anion transporters OATP1B1 (SLCO1B1), OATP1B3 (SLCO1B3) and OATP2B1 (SLCO2B1) | 2010 | 1 |
About Anna Vildhede
Anna Vildhede is a scholar working on Pharmacology, Oncology and Hepatology, having authored 23 papers that have together received 979 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (17 papers), Liver Disease Diagnosis and Treatment (8 papers), Pharmacogenetics and Drug Metabolism (8 papers), Pharmacological Effects and Toxicity Studies (4 papers), Drug-Induced Hepatotoxicity and Protection (4 papers), HIV/AIDS drug development and treatment (4 papers), Metabolism and Genetic Disorders (3 papers) and Liver physiology and pathology (2 papers). The work is most often cited by research in Pharmacology (349 citations), Oncology (583 citations) and Hepatology (108 citations). Anna Vildhede has collaborated with scholars based in United States, Sweden and Germany. Frequent co-authors include Per Artursson, Jacek R. Wiśniewski, Maria Karlgren, Agneta Norén, Emi Kimoto, Yurong Lai, U Haglund, Ulf Norinder, Manthena V. S. Varma and A. David Rodrigues. Their work appears in journals such as Drug Metabolism and Disposition, Journal of Pharmacology and Experimental Therapeutics, Clinical Pharmacology & Therapeutics, CPT Pharmacometrics & Systems Pharmacology and Journal of Pharmaceutical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.